Cloud-Based Mapping for Personalized Ablation

Withdrawn before enrolling

Conditions studied: Atrial Fibrillation, Arrhythmias, Cardiac

In brief

Atrial fibrillation is a serious public health issue that affects over 5 million Americans in whom it may cause skipped beats, dizziness, stroke and even death. This study seeks to improve our understanding of the causes of atrial fibrillation and to design new and more effective therapy for this heart rhythm disorder.

Key facts

Study ID

NCT04127123

Run by

Stanford University

People needed

0

Starts

2019-07-03

Expected to finish

2021-01-11

Last updated by the study team

2021-05-07

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• men and women of any ethnicity
• aged 21-80 years
• undergoing ablation of atrial fibrillation at Stanford University
• failed or be intolerant of ≥ 1 anti-arrhythmic drug or not willing to accept antiarrhythmic drug therapy.

You may not qualify if…

• active coronary ischemia or decompensated heart failure
• atrial or ventricular clot on trans-esophageal echocardiography
• pregnancy (to minimize fluoroscopic exposure)
• inability or unwillingness to provide informed consent
• rheumatic valve disease (because it results in a unique AF phenotype)
• thrombotic disease or venous filters
• significantly reduced kidney function

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.